Scientists have identified a bat coronavirus, designated KY43, that can bind to human lung cells, potentially posing a pandemic risk. The virus was discovered in bats native to East Africa and highlights the importance of proactive viral surveillance.

Discovery of the KY43 Coronavirus

The newly identified alphacoronavirus, KY43, originates from heart-nosed bats in Kenya, eastern Sudan, and northern Tanzania. Research indicates the virus can interact with a human cell receptor found in the lungs, raising concerns about potential cross-species transmission.

How the Virus Was Identified

An international research team utilized a database of genetic sequences to synthesize and screen alphacoronavirus spike proteins. This process identified KY43 as capable of entering human cells. The study challenges the previous understanding that alphacoronaviruses have limited host entry receptors.

Potential Pandemic Risk and Preparedness

While there is currently no evidence that KY43 has spread to the local human population, its ability to bind to human cells is a significant finding. Experts emphasize the need for further investigation in East Africa to understand the risks posed by related viruses.

Expert Perspectives

Dr. Dalan Bailey from The Pirbright Institute explained that the research reveals alphacoronaviruses may employ a variety of receptors to gain access to cells, expanding the potential for cross-species transmission. Professor Benjamin Neuman of Texas A&M University noted that KY43 is one of many viruses with the potential to jump from animals to humans.

Professor Aris Katzourakis from the University of Oxford, who was not involved in the study, described the research as a 'key early warning,' indicating that these viruses can overcome a crucial barrier to cross-species transmission.

Focus on Spike Proteins and Future Research

The research team focused on spike proteins, allowing for a safer investigation of potential human cell interactions. Further research is needed to determine if KY43 can effectively replicate within human cells and evade the immune system. Currently, there is no evidence of immune evasion.

The study, published in Nature, underscores the importance of continuous monitoring and research into emerging viral threats, particularly in regions with high biodiversity and close human-animal interactions. Sustained investment in scientific research and public health infrastructure is essential to mitigate future pandemic risks.